Navigation Links
Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan
Date:6/1/2009

n statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: clinical trial plans and timelines and clinical results for ProLindac and product candidates acquired in the MacroChem transaction, our ability to execute licensing agreements in the future, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Access Pharmaceuticals Provides Update on Global Launch of MuGard(TM)
2. LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide
3. Security Officers Who Protect Kaiser Hospitals Rally With Community Supporters for Access to Affordable Healthcare
4. Lingraphica introduces the SmallTalk mobile accessory for aphasia
5. Physical Therapists Advocate for Access to Rehabilitative Services on Capitol Hill
6. Communities Containing More Alcohol Outlets Show Increased Underage Alcohol Access
7. Viant Expands Relationship With HMA for Improved Healthcare Access in AZ
8. Access to environmental research in developing nations grown to 1,500 institutions
9. AccessRx.com Provides Same-Day Shipping for Tamiflu, an Effective Treatment for Swine Flu
10. Access to care leads Americans priorities in first-ever public study of health value
11. Access to Care Leads Americans Priorities in First-Ever Public Study of Health Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... (PRWEB) July 23, 2014 The puffiness ... diminished using non-surgical techniques, according to a new guide ... eyes serum sold in the U.S. is now available ... . , The complimentary guide that is now published ... struggle with under eye puffiness. While surgical techniques are ...
(Date:7/23/2014)... near Sellafield or Dounreay since the 1990s are not ... research published in the British Journal of Cancer ... Research Group at the University of Oxford and from ... among those who were under 25 and living near ... in cancer incidence from 1991-2006 between those living near ...
(Date:7/23/2014)... 23, 2014 Home Care ... of in-home care for seniors, announces the next ... featuring experts in a wide range of health ... licensed clinical social worker and award-winning author Nancy ... of caregiver stress and ways to prevent burnout ...
(Date:7/23/2014)... Lake Worth, FL (PRWEB) July 23, 2014 ... will take place Aug. 10-16, Millennium Treatment Group is ... Substance abuse has existed in society ever since man ... make wine. Substance abuse treatment has existed since shortly ... of recognizing a problem and then developing a way ...
(Date:7/23/2014)... Alan Mozes HealthDay Reporter ... servicemen are more likely to have been exposed to some ... new survey suggests. The finding seems to apply solely ... that the finding could be a cause for concern, given ... and/or sexual abuse among the civilian population has been linked ...
Breaking Medicine News(10 mins):Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3
... Allscripts-Misys Healthcare,Solutions, Inc. (formerly named Allscripts Healthcare ... Delaware ("Allscripts") and,headquartered in Chicago, Illinois announced today ... 3.50% Convertible Senior Debentures due 2024 (the,"Debentures") at ... equal to 100% of the principal amount of ...
... 7 Sagent Pharmaceuticals, Inc.,a privately-held specialty pharmaceutical company ... and Chief Executive,Officer Jeffrey M. Yordon will be presenting ... as follows., November: -- Jeffrey M. ... Annual Healthcare Conference on Wednesday, ...
... BioActiveX3 Complex(TM) features toxin-free ingredients, green chemistry technology in self-adjusting ... ... SALT LAKE CITY, Nov. 7 Global nutrition leader XanGo,LLC, today ... international convention in Salt Lake City. This personal care,brand features exclusive ...
... Society of ... Nephrology, HAYWARD, Calif., ... indicating that,its therapeutic product candidate AC-200 improved bone architecture in a,rat model ... was evaluated in a well accepted rodent model of,chronic kidney disease (CKD) ...
... Inc.,(Nasdaq: ENMD ) a clinical-stage pharmaceutical company ... diseases,announced today that James S. Burns, President and ... the Rodman and Renshaw 10th Annual,Healthcare Conference, which ... New,York Palace Hotel in New York, NY. Mr. ...
... CHICAGO, Nov. 7 Easter Seals elected Missouri resident,Kent ... board,s,recent meeting., "Kent is a passionate advocate for ... from Easter Seals services and as a,volunteer leader," said ... Seals. "He is a dedicated board member, donor and,fund ...
Cached Medicine News:Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 2Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 3Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 4Health News:Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences 2Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 2Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 3Health News:Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease 2Health News:Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease 3Health News:EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:Easter Seals Elects Kent Schien, Chief Executive Officer of St. Louis-based Innoventor, to the Organization's International Board of Directors 2
(Date:7/23/2014)... , July 23, 2014 Research ... "Disposable Medical Gloves (Exam and Surgical) Markets Worldwide ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of ... market for Disposable Medical (Exam and Surgical) Gloves. The ... market for these products. Topics covered include ...
(Date:7/23/2014)... 23, 2014  The management team at Columbia ... hold a conference call on July 31, 2014, ... ended June 30, 2014.  The call details are ... 8:30 am EDTDial-in numbers: , Toll free: (877) ... (live & archive): , www.columbialabs.com , under ...
(Date:7/23/2014)...  Silk Road Medical, Inc., a developer of ... and extra-cranial cerebrovascular disease, announced today the appointment ... position of Chief Technology Officer.  In this new ... Development efforts across its family of transcarotid access ... joining Silk Road Medical, Michael was the Vice ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... announces that a new market research report is available ... of Xylose in China http://www.reportlinker.com/p0260046/Production-and-Market-of-Xylose-in-China.html ... global financial crisis in Q4 2008, Chinese xylose production ... or even stopped production due to declining profit and ...
... improve vision-related quality of life in children compared with ... according to data drawn from a three-year multi-site study ... the self-perception of nearsighted children ages eight to 11 ... may be more considerable after 10 years of age. ...
Cached Medicine Technology:Reportlinker Adds Production and Market of Xylose in China 2Reportlinker Adds Production and Market of Xylose in China 3Children Report Better Vision-Related Quality of Life with Contact Lenses vs. Glasses 2
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: